263 related articles for article (PubMed ID: 31560112)
21. Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis.
Wang W; Zhang L; Liu W; Zhu Q; Lan Q; Zhao J
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1081-1089. PubMed ID: 26856461
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?
Ntalas IV; Milionis HJ; Kei AA; Kalantzi KI; Goudevenos JA
Angiology; 2014 Jul; 65(6):473-90. PubMed ID: 23966569
[TBL] [Abstract][Full Text] [Related]
23. Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS).
Diener HC; Bernstein R; Hart R
Curr Neurol Neurosci Rep; 2017 Sep; 17(9):64. PubMed ID: 28707135
[TBL] [Abstract][Full Text] [Related]
24. [Embolic stroke of undetermined source].
Vinogradov OI; Jablonskij MA; Kuznecov AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):42-48. PubMed ID: 33449532
[TBL] [Abstract][Full Text] [Related]
25. New opportunities to optimize antithrombotic therapy for secondary stroke prevention.
Kim AS; Easton JD
Int J Stroke; 2019 Apr; 14(3):220-222. PubMed ID: 30722755
[TBL] [Abstract][Full Text] [Related]
26. Letter by Meves and Neubauer regarding article "Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack".
Meves SH; Neubauer H
Stroke; 2012 Nov; 43(11):e167; author reply e168. PubMed ID: 23091124
[No Abstract] [Full Text] [Related]
27. Filling the gap between science & clinical practice: prevention of stroke recurrence.
Russolillo A; Di Minno MN; Tufano A; Prisco D; Di Minno G
Thromb Res; 2012 Jan; 129(1):3-8. PubMed ID: 21907395
[TBL] [Abstract][Full Text] [Related]
28. Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.
Kaplan ED; Sacco RL
Curr Neurol Neurosci Rep; 2002 Jan; 2(1):31-7. PubMed ID: 11898580
[TBL] [Abstract][Full Text] [Related]
29. Secondary prevention of stroke: a practical guide to drug treatment.
Koennecke HC
CNS Drugs; 2004; 18(4):221-41. PubMed ID: 15015903
[TBL] [Abstract][Full Text] [Related]
30. Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
Lalouschek W; Lang W; Müllner M;
Stroke; 2001 Dec; 32(12):2860-6. PubMed ID: 11739988
[TBL] [Abstract][Full Text] [Related]
31. Antithrombotic treatment in the prevention of ischemic stroke.
Emre U; Rantanen K; Tatlisumak T
Curr Drug Targets; 2007 Jul; 8(7):817-23. PubMed ID: 17630934
[TBL] [Abstract][Full Text] [Related]
32. Antithrombotic strategy in stroke.
Bousser MG
Thromb Haemost; 2001 Jul; 86(1):1-7. PubMed ID: 11486994
[TBL] [Abstract][Full Text] [Related]
33. [Antithrombotic drugs in the prevention of ischemic stroke].
Bousser MG
J Mal Vasc; 2005 Dec; 30(5):267-79. PubMed ID: 16439939
[TBL] [Abstract][Full Text] [Related]
34. Use of anticoagulants or antiplatelet aggregating drugs in the prevention of ischemic stroke.
Adams HP
Adv Intern Med; 1995; 40():503-31. PubMed ID: 7747656
[No Abstract] [Full Text] [Related]
35. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
Kasner SE; Lavados P; Sharma M; Wang Y; Wang Y; Dávalos A; Shamalov N; Cunha L; Lindgren A; Mikulik R; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi R; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni DS; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; DeVries Basson MM; Endres M; Muir K; Bornstein N; Ozturk S; O'Donnell M; Mundl H; Pater C; Weitz J; Peacock WF; Swaminathan B; Kirsch B; Berkowitz SD; Peters G; Pare G; Themeles E; Shoamanesh A; Connolly SJ; Hart RG;
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1673-1682. PubMed ID: 29525076
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the European and Japanese guidelines for the management of ischemic stroke.
Kern R; Nagayama M; Toyoda K; Steiner T; Hennerici MG; Shinohara Y
Cerebrovasc Dis; 2013; 35(5):402-18. PubMed ID: 23712178
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet and anticoagulation strategies in the prevention and treatment of ischemic stroke.
Kirshner HS
Curr Pharm Des; 2012; 18(33):5261-72. PubMed ID: 22724413
[TBL] [Abstract][Full Text] [Related]
38. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
39. Medical Management for Secondary Stroke Prevention.
Kim AS
Continuum (Minneap Minn); 2020 Apr; 26(2):435-456. PubMed ID: 32224760
[TBL] [Abstract][Full Text] [Related]
40. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL;
Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
